← Back to Search

Mushroom-Based Natural Product for COVID-19 Vaccination (MACH19 Trial)

N/A
Waitlist Available
Led By Andrew Shubov, MD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 180 days
Awards & highlights

MACH19 Trial Summary

This trial will study if mushrooms can help with a COVID-19 vaccine's effectiveness in a general population.

Eligible Conditions
  • COVID-19 Vaccination

MACH19 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~180 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 180 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alanine transaminase concentration
Albumine concentration
Aspartate transaminase concentration
+6 more
Secondary outcome measures
Peripheral Blood Mononuclear Cell (PBMC) immune profiling

MACH19 Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: MushroomsExperimental Treatment1 Intervention
Drug: FoTv The dosage of FoTv is 8 capsules three times a day for 4 consecutive days. It does not need to be consumed with food. It is best taken at least 30 minutes before OR at least 60 minutes after meals, in the morning, noon and evening. Accidentally missed doses will not need to be taken at a later time but will be recorded in a daily diary. Should swallowing capsules be an issue, they can be opened and dispensed into water or juice for easy ingestion.
Group II: PlaceboPlacebo Group1 Intervention
Placebo: organic brown rice The dosage of Placebo is 8 capsules three times a day for 4 consecutive days. It does not need to be consumed with food. It is best taken at least 30 minutes before OR at least 60 minutes after meals, in the morning, noon and evening. Accidentally missed doses will not need to be taken at a later time but will be recorded in a daily diary. Should swallowing capsules be an issue, they can be opened and dispensed into water or juice for easy ingestion.

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,120 Previous Clinical Trials
1,521,317 Total Patients Enrolled
Andrew Shubov, MDPrincipal InvestigatorUniversity of California, Los Angeles
3 Previous Clinical Trials
214 Total Patients Enrolled

Media Library

FoTv Clinical Trial Eligibility Overview. Trial Name: NCT04951336 — N/A
COVID-19 Vaccination Research Study Groups: Mushrooms, Placebo
COVID-19 Vaccination Clinical Trial 2023: FoTv Highlights & Side Effects. Trial Name: NCT04951336 — N/A
FoTv 2023 Treatment Timeline for Medical Study. Trial Name: NCT04951336 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
California
How old are they?
65+
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
RCT of Mushroom Based Natural Product to Enhance Immune Response to COVID-19 Vaccination
Gordon Saxe 2021. "RCT of Mushroom Based Natural Product to Enhance Immune Response to COVID-19 Vaccination". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04951336.
~23 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top